Occurrence of micropollutants in rural domestic wastewater in Zhejiang Province, China and corresponding wastewater-based epidemiology analysis

Abstract

By 2021, rural regions in China were occupied by over 500 million residents, generating an annual volume of 19.5 billion m3 of rural domestic wastewater (RDW). This study aimed to investigate the occurrence and removal of micropollutants (MPs) in RDW treatment facilities and to perform a corresponding wastewater-based epidemiology analysis (WBE). Our findings indicated the significantly high levels of influent MPs, particularly pharmaceuticals, such as ofloxacin and diclofenac being most prevalent (ranging from several to tens of μg/L) across different facilities. After various treatments, regular water indexes in the effluent, like NH3 -N and COD, have basically satisfied the local discharge standard. However, the concentration of certain dominant MPs in effluent remained notably high, ranging from hundreds of ng/L to several μg/L. The risk quotients of MPs like diclofenac, ciprofloxacin, ofloxacin, sulfamethoxazole, diuron, and isoproturon were all above 1 in the effluent, signifying significant hazards to aquatic organisms. The quantitative meta-analysis revealed higher average standardized removal efficiency for membrane bioreactor (MBR) treatment (-11 %) compared to anaerobic/anoxic/aerobic (A2O) treatment (11 %), indicating the higher efficiency of MBR treatment in outperforming the A2O as a secondary treatment. Additionally, employing biofilter as a tertiary treatment proved to be more effective as compared to flocculation-air flotation and artificial wetlands. Moreover, the results of WBE analysis showed that diclofenac and ofloxacin emerged as the most commonly used pharmaceuticals (of seven), with consumption levels recorded at 1222 and 517 mg/(d·103 capita), with daily defined doses per day per 103 capita of 12.2/1000 and 1.29/1000, respectively. This study addresses the existing knowledge gaps regarding the occurrence and removal of MPs in RDW and offers valuable insights into pharmaceutical consumption patterns in rural regions, thereby improving our understanding of public health.